Please assess the completion status of the following clinical trial:

Trial Title: Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who are 19 years or older on screening~* Signed informed consent~* Patients with Essential Hypertension~* Other inclusion applied~Exclusion Criteria:~* Orthostatic hypotension~* Other exclusion applied

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Irbesartan/Amlodipine low (Type: EXPERIMENTAL): None
- Irbesartan/Amlodipine high (Type: EXPERIMENTAL): None
- Irbesartan (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).